Vanguard Group Inc Nautilus Biotechnology, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,778,449 shares of NAUT stock, worth $3.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,778,449

Previous 2,766,343 0.44%

Holding current value

$3.25 Million

Previous $7.88 Million 40.8%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$1.67 - $2.96 $20,217 - $35,833	12,106 Added 0.44%	2,778,449 $4.67 Million
Q3 2024 Nov 13, 2024	BUY	$2.24 - $3.08 $95,753 - $131,660	42,747 Added 1.57%	2,766,343 $7.88 Million
Q2 2024 Aug 13, 2024	SELL	$2.22 - $3.0 $301,489 - $407,418	-135,806 Reduced 4.75%	2,723,596 $6.37 Million
Q1 2024 May 10, 2024	BUY	$2.41 - $3.18 $71,345 - $94,140	29,604 Added 1.05%	2,859,402 $8.41 Million
Q4 2023 Feb 14, 2024	BUY	$2.34 - $3.39 $50,574 - $73,268	21,613 Added 0.77%	2,829,798 $8.46 Million
Q3 2023 Nov 14, 2023	BUY	$2.87 - $3.94 $18,020 - $24,739	6,279 Added 0.22%	2,808,185 $8.87 Million
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.52 $84,631 - $173,093	-38,295 Reduced 1.35%	2,801,906 $10.8 Million
Q1 2023 May 15, 2023	BUY	$1.67 - $2.77 $1.11 Million - $1.84 Million	664,825 Added 30.56%	2,840,201 $7.87 Million
Q4 2022 Feb 10, 2023	SELL	$1.55 - $2.47 $2,035 - $3,243	-1,313 Reduced 0.06%	2,175,376 $3.92 Million
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.13 $7,116 - $11,365	-3,631 Reduced 0.17%	2,176,689 $4.61 Million
Q2 2022 Aug 12, 2022	SELL	$2.64 - $4.84 $453,063 - $830,616	-171,615 Reduced 7.3%	2,180,320 $5.87 Million
Q1 2022 May 13, 2022	BUY	$3.5 - $5.3 $3.73 Million - $5.65 Million	1,066,638 Added 82.99%	2,351,935 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$4.45 - $6.21 $3.11 Million - $4.34 Million	699,435 Added 119.39%	1,285,297 $6.66 Million
Q3 2021 Nov 12, 2021	BUY	$6.14 - $10.1 $3.6 Million - $5.92 Million	585,862 New	585,862 $3.6 Million

Others Institutions Holding NAUT

# of Institutions

Shares Held

64.5M

Call Options Held

Put Options Held

View Full List

About Nautilus Biotechnology, Inc.

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $146M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

More about NAUT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Nautilus Biotechnology, Inc. Transaction History